Literature DB >> 26415688

Antibiotic dose optimization in critically ill patients.

M O Cotta1, J A Roberts2, J Lipman3.   

Abstract

The judicious use of existing antibiotics is essential for preserving their activity against infections. In the era of multi-drug resistance, this is of particular importance in clinical areas characterized by high antibiotic use, such as the ICU. Antibiotic dose optimization in critically ill patients requires sound knowledge not only of the altered physiology in serious infections - including severe sepsis, septic shock and ventilator-associated pneumonia - but also of the pathogen-drug exposure relationship (i.e. pharmacokinetic/pharmacodynamic index). An important consideration is the fact that extreme shifts in organ function, such as those seen in hyperdynamic patients or those with multiple organ dysfunction syndrome, can have an impact upon drug exposure, and constant vigilance is required when reviewing antibiotic dosing regimens in the critically ill. The use of continuous renal replacement therapy and extracorporeal membrane oxygenation remain important interventions in these patients; however, both of these treatments can have a profound effect on antibiotic exposure. We suggest placing emphasis on the use of therapeutic drug monitoring and dose individualization when optimizing therapy in these settings.
Copyright © 2015 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.

Entities:  

Keywords:  Antibiotics; Antibióticos; Choque séptico; Critically ill; Críticamente enfermo; Dose optimization; Optimización de la dosis; Sepsis grave; Septic shock; Severe sepsis

Mesh:

Substances:

Year:  2015        PMID: 26415688     DOI: 10.1016/j.medin.2015.07.009

Source DB:  PubMed          Journal:  Med Intensiva        ISSN: 0210-5691            Impact factor:   2.491


  12 in total

1.  Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients: Is Augmented Renal Clearance What We Really Want to Know? Some Suggested Management Approaches and Clinical Software Tools.

Authors:  Roger Jelliffe
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

2.  Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Authors:  Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres
Journal:  Intensive Care Med       Date:  2020-02       Impact factor: 17.440

3.  High target attainment for β-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied.

Authors:  H Woksepp; A Hällgren; S Borgström; F Kullberg; A Wimmerstedt; A Oscarsson; P Nordlund; M-L Lindholm; J Bonnedahl; L Brudin; B Carlsson; T Schön
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-04       Impact factor: 3.267

4.  Sustainable implementation of antibiotic stewardship on a surgical intensive care unit evaluated over a 10-year period.

Authors:  Stefan Schröder; Marie-Kathrin Klein; Bernhard Heising; Sebastian W Lemmen
Journal:  Infection       Date:  2019-11-13       Impact factor: 3.553

5.  The correlation between non-O blood group type and recurrent catheter-associated urinary tract infections in critically ill patients: A retrospective study.

Authors:  Khalid Al Sulaiman; Nouf Al Qahtani; Mashael Al Muqrin; Maram Al Dossari; Ali Al Wabel; Tareq Al Sulaiman; Ramesh Vishwakarma; Abdulaziz Alolayan; Fatimah Abudayah; Ghazwa B Korayem; Ohoud Aljuhani
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

6.  Right Dose, Right Now: Development of AutoKinetics for Real Time Model Informed Precision Antibiotic Dosing Decision Support at the Bedside of Critically Ill Patients.

Authors:  Luca F Roggeveen; Tingjie Guo; Ronald H Driessen; Lucas M Fleuren; Patrick Thoral; Peter H J van der Voort; Armand R J Girbes; Rob J Bosman; Paul Elbers
Journal:  Front Pharmacol       Date:  2020-05-15       Impact factor: 5.810

Review 7.  The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials.

Authors:  Alicia Rodríguez-Gascón; María Ángeles Solinís; Arantxa Isla
Journal:  Pharmaceutics       Date:  2021-06-03       Impact factor: 6.321

8.  Damage control orthopaedics: State of the art.

Authors:  Enrique Guerado; Maria Luisa Bertrand; Juan Ramon Cano; Ana María Cerván; Adolfo Galán
Journal:  World J Orthop       Date:  2019-01-18

Review 9.  Optimizing Antimicrobial Drug Dosing in Critically Ill Patients.

Authors:  Pedro Póvoa; Patrícia Moniz; João Gonçalves Pereira; Luís Coelho
Journal:  Microorganisms       Date:  2021-06-28

Review 10.  Antibiotics and the Nervous System-Which Face of Antibiotic Therapy Is Real, Dr. Jekyll (Neurotoxicity) or Mr. Hyde (Neuroprotection)?

Authors:  Magdalena Hurkacz; Lukasz Dobrek; Anna Wiela-Hojeńska
Journal:  Molecules       Date:  2021-12-09       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.